Friday, November 4, 2016 at 7 PM - 9 PM
CIIS Public Programs & Performances
1453 Mission St,
San Francisco, California 94103
FDA-approved clinical trials at Johns Hopkins University and NYU School of Medicine have evaluated the effects of a psilocybin-facilitated mystical experience with diverse populations including individuals diagnosed with cancer experiencing psycho-spiritual and existential distress-many of these patients at the end of life. Subjective features of a mystical experience include unity, sacredness, transcendence, and a greater connection to deeply felt positive emotions including that of love.
This evening presentation and panel discussion explores the prominent, meaning-making, and transformative experiences of love and agape (spiritual, transcendent, or highest form of selfless love) that frequently emerge in psilocybin sessions. The panel discussion includes background information on psilocybin research and clinical case vignettes on the emergence of love within the psilocybin-facilitated mystical experience and its role in cultivating compassion and promoting healing. This event includes time for panel question and answer period moderated by Janis Phelps, Director of the Center for Psychedelic Therapies and Research.
This event is an educational program of the CIIS Center for Psychedelic Therapies and Research in collaboration with CIIS Public Programs & Performances.